Diabetes

Diabetes drug spending is on the rise, but there are ways to control it.

Prepare for major pipeline developments in diabetes, autoimmune disorders, oncology, and COPD.

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.

A real-world study of type 2 diabetes patients by Milliman has surprising findings on glycemic control and diabetes medication adherence.

Experts share updates on new diabetes medications, and provide an overview of what’s coming.

Find out about the latest treatment and drug pipeline developments

Two reports highlight areas of elderly care that healthcare systems and health plans should avoid.

Several recent studies explore how weight loss surgery impacts diabetes patient care.

Mayo Clinic researchers found that beyond overtesting, focus on HbA1C levels can lead to serious harms for patients, especially as more diabetes drugs are needed to keep HbA1C within desired targets.

A large-scale observational study led by Columbia University researchers may offer new approach to studying diverse patient groups.

Study seeks to determine whether significant improvement in glycemic control can be achieved when regular coaching is part of the process.

We recently asked experts to define the top challenges associated with diabetes health management, and how health plans can overcome them.

How much does diabetes cost the healthcare system and what's driving cost increases? Find out.

Here’s how remote monitoring works to improve diabetic patient care, and a look at whether payers are paying for it.

Novo Nordisk’s new diabetes drug production facility in Clayton, N.C., will ensure production capacity for these drugs in the United States for the decade ahead.

A systemic review highlights studies that improved medication adherence and patient outcomes using strategies that could be effective if employed in real-world healthcare settings.

Studies have found that getting diabetes under control early on has immediate benefits. Here’s how providers and patients can more proactively address the disease.

Specific benefits patients with diabetes have experienced due to the ACA, and how those benefits are impacting diabetes costs.

Although the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes.

Personalization is the key to a healthcare experience that optimizes outcomes, improves the customer experience and, ultimately, lowers costs to the healthcare system. Find out why it’s especially key for diabetic patients.

Mobile health (mHealth) offers new ways to empower patients with diabetes in caring for themselves and making decisions that support their health.

Telemedicine could improve diabetic patient outcomes, expand access, and provide better economic value for patients. Find out how.

Consequences range from cardiovascular disease to renal disease

Here are some of the innovative approaches payers and providers are taking to quell the diabetes epidemic, and curb the costs associated with it.

A successful YMCA diabetes program has prompted the Obama administration to expand Medicare to cover programs to prevent diabetes among those at high risk of developing the disease.

The sheer volume of diabetes patients has made it a big driver of medication spending. Here are some important formulary considerations.

… and solutions from experts

Rob Danoff, DO, of Aria Health System, explains what should be done to reduce health management costs, while improving care of diabetic patients.

In this Q&A, experts discuss how emerging treatments and technologies are affecting diabetes costs.